THE C12-200 DIARIES

In scientific trials assessing the utmost tolerated dose of gemcitabine for injection, prolongation on the infusion time further than sixty minutes or more Repeated than weekly dosing resulted in an increased incidence of clinically substantial hypotension, severe flu-like symptoms, myelosuppression, and asthenia.The two Adult males and women using